Skip to main content navigationSkip to main content
ASCRS U
  • Home
  • Favorites
  • Notes
  • Prime PubMed
  • CME
  • Mobile
  • Browse
Log in
Fundamentals of Rectal Cancer SurgeryFundamentals of Rectal Cancer Surgery

Tags

Type your tag names separated by a space and hit enter

+

Indications for Extended Resection

Indications for Extended Resection is a topic covered in the Fundamentals of Rectal Cancer Surgery.

To view the entire topic, please log in or purchase a subscription.

ASCRS U Education Portal is the one-stop place for all things related to colorectal surgery. Provided by the American Society of Colon & Rectal Surgeons. Powered by Unbound Medicine. Explore these free sample topics:

ASCRS U

Anatomy and Embryology of the Colon, Rectum, and AnusAnatomy and Embryology of the Colon, Rectum, and Anus

Finding the correct TME planeFinding the correct TME plane

Colonic Diverticular DiseaseColonic Diverticular Disease

Surgical Management of Ulcerative ColitisSurgical Management of Ulcerative Colitis

-- The first section of this topic is shown below --

Pelvic Exenteration

Approximately 5% to 8.8% of patients who present with colorectal cancer will have tumors that spread beyond the anatomic landmarks of a standard TME resection.[1],[2] T4 tumors have a worse overall prognosis, and decision-making for these patients must be multidisciplinary and highly individualized.[3] For patients who are fit enough to undergo aggressive treatment and willing to accept a high degree of treatment-related morbidity, curative-intent treatment may be pursued. In this context, the most important goal in surgical planning is obtain a histologically negative margin (R0 resection), even if resection of multiple organs and structures is required to do so.

Care of these patients begins with a thorough, patient-specific evaluation including imaging, medical evaluation, preoperative counseling of functional expectations, and potential stoma counseling and education.[1] The extension of tumor beyond the confines of the mesorectum is best assessed by magnetic resonance imaging (MRI).[2] Once identified, these patients require care from a multidisciplinary team, with surgical (e.g., colorectal surgery, gynecology, neurosurgery, orthopedic surgery, plastic and reconstructive surgery, spine surgery, urology), oncology, radiation oncology, radiology, and pathological expertise and experience in pelvic exenteration. Nearly all patients with these more locally-advanced primary tumors (beyond the normal TME planes) undergo chemoradiation therapy prior to surgery.

Optimal patient selection begins with a thorough assessment of the patient’s performance status and overall health. Those individuals with significant functional impairments and comorbidities are often not considered acceptable surgical candidates. The patient’s emotional preparedness for undergoing this extensive treatment should be evaluated. He/she should be well informed of the functional effects of the planned surgery as well as the short- and long-term risks of complications.[3]

The next step in this process requires the assessment of the anatomical relationships of the tumor and its potential involvement of adjacent pelvic organs and structures. The primary goal of surgery is the achievement of an R0 resection, that is, resection with histologically negative margins. Surgical planning with the aid of a high-resolution MRI can best plan for the required resection of the potentially involved structures and insurance of an en bloc resection. A PET-CT scan in addition to the usual CT scan of the chest, abdomen, and pelvis may aid in the detection of occult extra pelvic disease. This imaging modality may assist in excluding patients from futile radical resections in attempts at cure.

The presence of any metastatic disease complicates the decision to pursue pelvic exenteration. Extensive metastatic disease is a contraindication to exenteration; however, patients with limited metastatic disease may be considered for extensive surgery. The role of a multidisciplinary tumor conference is essential in establishing a patient-specific treatment plan. All patients with locally advanced rectal cancer are referred for neoadjuvant chemoradiation therapy. Multimodality therapy including external beam radiation therapy and neoadjuvant/adjuvant chemotherapy and potential intraoperative radiation therapy (IORT) are considered in maximizing local control and improving patient survival. Although there are inherent limitations of post-treatment imaging, patients with these types of tumors should generally be rescanned after completing treatment prior to surgery.

The contraindications and limitations of resectability are debated, and these limitations concentrate on the ability to achieve an R0 resection with an acceptable risk for postoperative morbidity. However, these decisions are best made at experienced centers with the appropriate expertise in pelvic exenteration.

There are four main anatomical categories of tumors requiring extended proctectomy:[4]

  • Axial tumors involve the central pelvic organs and do not invade the anterior, posterior, or lateral pelvic walls.
  • Anterior tumors invade the bladder, vagina, uterus, seminal vesicles, and/or prostate.
  • Posterior tumors invade the sacrum and/or coccyx
  • The most challenging are lateral tumors, which involve the bony pelvic side wall or side-wall structures, including the iliac vessels, pelvic ureters, lateral lymph nodes, pelvic autonomic nerves, and side-wall musculature.

Pelvic exenteration surgery can be described using these anatomic regions, for example "anterior exenteration" for rectal cancer involves excision of the rectum and mesorectum en bloc with anterior structures (Figure 6.1).

Figure 6.1
Descriptive text is not available for this image

The contraindications to pelvic exenteration are patient preference, lack of appropriate fitness, inoperable metastatic disease, and tumor extending to the S1 level of the sacrum. The relative contraindications are distant metastases, metastases to para-aortic lymph nodes, and tumor fixed to more than one non-axial pelvic structure.[3] It is institution-dependent if lateral recurrences are a contraindication to a pelvic exenteration. Many perform this surgery with experienced teams after careful assessment of what would be required for en bloc resection to attain a R0 resection.[5] Evidence of bilateral ureteral obstruction may be associated with involvement the bladder trigone or bilateral pelvic sidewall infiltration.

Preoperative enterostomal therapist counselling for marking and education is critical to the successful postoperative outcomes associated with the potential need for a colostomy and/or urostomy. Urological consultation for placement of ureteral stents is helpful in assisting in identification of the ureters and their potential involvement in the required resection. Plastic and reconstructive surgical consultation for perineal defect reconstruction is essential in minimizing risks of wound complications. The options include a rectus myocutaneous flap, gracilis muscle flap, gluteal rotational flap, free flap, or biological mesh with omentoplasty.

It is critical in successful planning for a pelvic exenteration to include a discussion regarding functional outcomes and expectations. These include the quality of life changes associated with a potential colostomy, urostomy, and compromise to pelvic nerves including bowel, sexual, and urinary dysfunction.

-- To view the remaining sections of this topic, please log in or purchase a subscription --

Pelvic Exenteration

Approximately 5% to 8.8% of patients who present with colorectal cancer will have tumors that spread beyond the anatomic landmarks of a standard TME resection.[1],[2] T4 tumors have a worse overall prognosis, and decision-making for these patients must be multidisciplinary and highly individualized.[3] For patients who are fit enough to undergo aggressive treatment and willing to accept a high degree of treatment-related morbidity, curative-intent treatment may be pursued. In this context, the most important goal in surgical planning is obtain a histologically negative margin (R0 resection), even if resection of multiple organs and structures is required to do so.

Care of these patients begins with a thorough, patient-specific evaluation including imaging, medical evaluation, preoperative counseling of functional expectations, and potential stoma counseling and education.[1] The extension of tumor beyond the confines of the mesorectum is best assessed by magnetic resonance imaging (MRI).[2] Once identified, these patients require care from a multidisciplinary team, with surgical (e.g., colorectal surgery, gynecology, neurosurgery, orthopedic surgery, plastic and reconstructive surgery, spine surgery, urology), oncology, radiation oncology, radiology, and pathological expertise and experience in pelvic exenteration. Nearly all patients with these more locally-advanced primary tumors (beyond the normal TME planes) undergo chemoradiation therapy prior to surgery.

Optimal patient selection begins with a thorough assessment of the patient’s performance status and overall health. Those individuals with significant functional impairments and comorbidities are often not considered acceptable surgical candidates. The patient’s emotional preparedness for undergoing this extensive treatment should be evaluated. He/she should be well informed of the functional effects of the planned surgery as well as the short- and long-term risks of complications.[3]

The next step in this process requires the assessment of the anatomical relationships of the tumor and its potential involvement of adjacent pelvic organs and structures. The primary goal of surgery is the achievement of an R0 resection, that is, resection with histologically negative margins. Surgical planning with the aid of a high-resolution MRI can best plan for the required resection of the potentially involved structures and insurance of an en bloc resection. A PET-CT scan in addition to the usual CT scan of the chest, abdomen, and pelvis may aid in the detection of occult extra pelvic disease. This imaging modality may assist in excluding patients from futile radical resections in attempts at cure.

The presence of any metastatic disease complicates the decision to pursue pelvic exenteration. Extensive metastatic disease is a contraindication to exenteration; however, patients with limited metastatic disease may be considered for extensive surgery. The role of a multidisciplinary tumor conference is essential in establishing a patient-specific treatment plan. All patients with locally advanced rectal cancer are referred for neoadjuvant chemoradiation therapy. Multimodality therapy including external beam radiation therapy and neoadjuvant/adjuvant chemotherapy and potential intraoperative radiation therapy (IORT) are considered in maximizing local control and improving patient survival. Although there are inherent limitations of post-treatment imaging, patients with these types of tumors should generally be rescanned after completing treatment prior to surgery.

The contraindications and limitations of resectability are debated, and these limitations concentrate on the ability to achieve an R0 resection with an acceptable risk for postoperative morbidity. However, these decisions are best made at experienced centers with the appropriate expertise in pelvic exenteration.

There are four main anatomical categories of tumors requiring extended proctectomy:[4]

  • Axial tumors involve the central pelvic organs and do not invade the anterior, posterior, or lateral pelvic walls.
  • Anterior tumors invade the bladder, vagina, uterus, seminal vesicles, and/or prostate.
  • Posterior tumors invade the sacrum and/or coccyx
  • The most challenging are lateral tumors, which involve the bony pelvic side wall or side-wall structures, including the iliac vessels, pelvic ureters, lateral lymph nodes, pelvic autonomic nerves, and side-wall musculature.

Pelvic exenteration surgery can be described using these anatomic regions, for example "anterior exenteration" for rectal cancer involves excision of the rectum and mesorectum en bloc with anterior structures (Figure 6.1).

Figure 6.1
Descriptive text is not available for this image

The contraindications to pelvic exenteration are patient preference, lack of appropriate fitness, inoperable metastatic disease, and tumor extending to the S1 level of the sacrum. The relative contraindications are distant metastases, metastases to para-aortic lymph nodes, and tumor fixed to more than one non-axial pelvic structure.[3] It is institution-dependent if lateral recurrences are a contraindication to a pelvic exenteration. Many perform this surgery with experienced teams after careful assessment of what would be required for en bloc resection to attain a R0 resection.[5] Evidence of bilateral ureteral obstruction may be associated with involvement the bladder trigone or bilateral pelvic sidewall infiltration.

Preoperative enterostomal therapist counselling for marking and education is critical to the successful postoperative outcomes associated with the potential need for a colostomy and/or urostomy. Urological consultation for placement of ureteral stents is helpful in assisting in identification of the ureters and their potential involvement in the required resection. Plastic and reconstructive surgical consultation for perineal defect reconstruction is essential in minimizing risks of wound complications. The options include a rectus myocutaneous flap, gracilis muscle flap, gluteal rotational flap, free flap, or biological mesh with omentoplasty.

It is critical in successful planning for a pelvic exenteration to include a discussion regarding functional outcomes and expectations. These include the quality of life changes associated with a potential colostomy, urostomy, and compromise to pelvic nerves including bowel, sexual, and urinary dysfunction.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: September 17, 2021

Citation

"Indications for Extended Resection." Fundamentals of Rectal Cancer Surgery, 2021. ASCRS U, www.ascrsu.com/ascrs/view/Fundamentals-of-Rectal-Cancer-Surgery/2831009/all/Indications for Extended Resection.
Indications for Extended Resection. Fundamentals of Rectal Cancer Surgery. 2021. https://www.ascrsu.com/ascrs/view/Fundamentals-of-Rectal-Cancer-Surgery/2831009/all/Indications for Extended Resection. Accessed March 21, 2023.
Indications for Extended Resection. (2021). In Fundamentals of Rectal Cancer Surgery https://www.ascrsu.com/ascrs/view/Fundamentals-of-Rectal-Cancer-Surgery/2831009/all/Indications for Extended Resection
Indications for Extended Resection [Internet]. In: Fundamentals of Rectal Cancer Surgery. ; 2021. [cited 2023 March 21]. Available from: https://www.ascrsu.com/ascrs/view/Fundamentals-of-Rectal-Cancer-Surgery/2831009/all/Indications for Extended Resection.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Indications for Extended Resection ID - 2831009 Y1 - 2021/09/17/ BT - Fundamentals of Rectal Cancer Surgery UR - https://www.ascrsu.com/ascrs/view/Fundamentals-of-Rectal-Cancer-Surgery/2831009/all/Indications for Extended Resection DB - ASCRS U DP - Unbound Medicine ER -
ᐸ PreviousNext ᐳ
Try the app for free!

1. Download the ASCRS U app by Unbound Medicine

2. Select Try/Buy and follow instructions to begin your free 30-day trial

You can cancel anytime within the 30-day trial, or continue using ASCRS U to begin a 1-year subscription ($39.95)
Appstore
Google Play
Grapherence® [↑15]
    • Fundamentals of Rectal Cancer Surgery
    • Background
    • Rectal Anatomy
    • Rectal Cancer Biology and Hereditary Cancer Syndromes
    • Rationale for Multi-Modality Therapy
    • Preoperative Issues
    • Preoperative Staging
    • Role of Tumor Board
    • Indications for Preoperative Neoadjuvant Therapy
    • Local Excision
    • Indications for LAR Versus Intersphincteric Resection Versus APR
    • Indications for Extended Resection
    • Preoperative Preparation
    • Interoperative
    • Patient Positioning and Equipment for Rectal Cancer Surgery
    • Inferior Mesenteric Artery
    • Inferior Mesenteric Vein (IMV)
    • Splenic Flexure Mobilization
    • Surgical Techniques for Length
    • Technique of Total Mesorectal Excision (TME)
    • Tailored Mesorectal Excision (TME)
    • Bowel Transection and Anastomosis
    • Indications for Fecal Diversion
    • Abdominoperineal Resection
    • Standardized Operative Report
    • Management of Intraoperative Vascular and Urinary Complications
    • Postoperative Issues
    • Rectal Cancer Pathology Assessment
    • Adjuvant Therapy for Rectal Adenocarcinoma
    • Surveillance After Rectal Cancer Treatment
    • Management of Local Recurrences
    • Short-Term Complications - Anastomotic
    • Short-Term Complications - Urinary
    • Ostomy Complications and Management
    • Long-Term Complications – Bowel Dysfunction
    • Long-Term Complications - Sexual Dysfunction and Its Management
    • Parastomal and Perineal Hernias
    • Impact of Postoperative Complications On Oncologic Outcomes
    • Course Complete
    • Final Assessment
Grapherence® [↑15]
Search PRIME PubMed

Related Topics

  • Surgical Management of Crohn's Disease
  • Benign Colorectal Disease Trauma of the Colon and Rectum
  • Rectal Cancer Biology and Hereditary Cancer Syndromes
  • Management of Rectal Cancer
  • Perioperative Evaluation and Management of Frailty Among Older Adults Undergoing Colorectal Surgery
  • Preoperative Evaluation in Colorectal Patients
  • Management of Clostridioides difficile Infection
Your free 1 year of online access expired  .

Want to regain access to ASCRS U?

Note: Your username may be different from the email address used to register your account.

Contact Support

If you need further assistance, please contact Support.
  • unboundmedicine.com/support
  • support@unboundmedicine.com
  • 610-627-9090(Monday - Friday, 9 AM - 5 PM EST.)
Password reset sent
Username sent

Log In

ASCRS U Education Portal

Individual subscription from ASCRSLog in
A ASCRS U subscription is required to
Already have an account?Log In
Want to read the entire topic?
ASCRS offers multipe educational resources for a solid foundation in the evaluation and management of colorectal disease.
Purchase a subscriptionI’m already a subscriber
Browse sample topics
Feedback
Message
Preferred form of contact
Best time to call:
Send Message
logo
  • Home
  • Contact Us
  • Privacy / Disclaimer
  • Terms of Service
  • Log in

American Society of Colon and Rectal Surgeons & Unbound Medicine, Inc. All rights reserved.

Powered By
6.0-3971